<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001999371-26-010119</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Medtronic plc -->
          <cik>0001613103</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>10/15/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0002062583</issuerCik>
        <issuerName>MiniMed Group, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>60365F109</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>18000 Devonshire Street</com:street1>
          <com:city>Northridge</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>91325</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Medtronic plc</reportingPersonName>
      <citizenshipOrOrganization>L2</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>0.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0.0</classPercent>
      <typeOfReportingPerson>FI</typeOfReportingPerson>
      <comments>On October 15, 2026, Medtronic plc ("Medtronic") completed the separation of MiniMed Group, Inc. (the "Issuer") through a split-off exchange offer (the "Exchange Offer"), pursuant to which Medtronic exchanged shares of common stock, par value $0.01 per share (the "Common Stock"), of the Issuer representing approximately 90% of shares of outstanding Common Stock for outstanding ordinary shares of Medtronic held by Medtronic shareholders. As a result of the Exchange Offer, Medtronic ceased to own any shares of Common Stock of the Issuer. This Amendment No. 1 to the Schedule 13G is being filed to reflect the fact that Medtronic no longer holds more than 5% of the Common Stock of the Issuer, and has ceased to be a Schedule 13G reporting person with regard to the Common Stock.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>MiniMed Group, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>18000 Devonshire Street, Northridge, CA 91325</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Medtronic plc</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Building Two, Parkmore Business Park West, Galway, Ireland H91 4K49</principalBusinessOfficeOrResidenceAddress>
        <citizenship>L2</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>0</amountBeneficiallyOwned>
        <classPercent>0.0%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Medtronic plc</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Brian Sandstrom</signature>
        <title>Brian Sandstrom/VP, Chief Corporate and Securities Counsel</title>
        <date>10/16/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
